ApprovalTrail

Approval · Notice of Compliance 2373 · 2001

LOPERAMIDE: Notice of Compliance 2373

Issued July 6, 2001

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2373
Date
July 6, 2001
Company
D.C. Labs LimitedMarkham, Ontario, Canada
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Change in product and manufacturer name
Therapeutic class
Antidiarrheal

Products in this notice

BrandDINStatus today
LOPERAMIDE02244262Cancelled Post Market

Medicinal ingredients